IR@PKUHSC  > 北京大学精神卫生研究所
学科主题精神卫生
Remission Rate and Functional Outcomes During a 6-Month Treatment With Osmotic-Release Oral-System Methylphenidate in Children With Attention-Deficit/Hyperactivity Disorder
Su, Yi1; Li, Haibo2; Chen, Yixin3; Fang, Fang4; Xu, Tong5; Lu, Haiping6; Xie, Ling7; Zhuo, Jianmin8; Qu, Jiazhi8; Yang, Li1; Wang, Yufeng1
关键词Attention-deficit Hyperactivity Disorder Executive Methylphenidate Remission Social
刊名JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
2015-10-01
DOI10.1097/JCP.0000000000000389
35期:5页:525-534
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Pharmacology & Pharmacy ; Psychiatry
研究领域[WOS]Pharmacology & Pharmacy ; Psychiatry
关键词[WOS]DEFICIT-HYPERACTIVITY DISORDER ; QUALITY-OF-LIFE ; OROS METHYLPHENIDATE ; ADHD ; SYMPTOMS ; PREVALENCE ; IMPACT ; ADOLESCENTS ; ADULTS ; GOAL
英文摘要

Many definitions have been used to evaluate remission in patients with attention-deficit/hyperactivity disorder (ADHD) in different studies resulting with varied remission rates. This open-label, multicenter study investigated the remission rate in Chinese children (n = 239; aged 6-16 years) with a diagnosis of ADHD (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition), treated with osmotic-release oral-system methylphenidate at doses of 18, 36, and 54 mg, once daily. Two definitions of remission were used: (1) (primary end point): average scores of SNAP-IV (Swanson, Nolan, and Pelham, Fourth Edition) items of 1 or less (0-3 rating scale for each item) according to the subtype of ADHD (inattentive [1-9], hyperactive-impulsive [10-18], and combined type [1-18]), and (2) total score of SNAP-IV items 1 to 18 of 18 or less, at week 8. The study consisted of screening/baseline, titration/open-label treatment (8 weeks), and extended observation (up to 24 weeks) phases. Secondary efficacy assessments were Clinical Global Impression-Improvement (clinical efficacy), Behavior Rating Inventory of Executive Function Scale (BRIEF; executive function behaviors), and Weiss Functional Impairment Rating Scale (social function). Validity of remission was assessed by comparing the function measures (BRIEF and Weiss′s) between patients who achieved remission and those who did not. At week 8, 69.3% (151/218) of patients achieved remission by definition 1, and 73.2% (161/220) by definition 2. At weeks 8 and 24, the remission group had significantly lower BRIEF, Weiss′s, and Clinical Global Impression-Improvement scores (P < 0.001 for all) compared with the nonremission group. Overall, treatment with osmotic-release oral-system methylphenidate was well tolerated, with increased remission rates in children with ADHD.

语种英语
WOS记录号WOS:000361036100006
项目编号2014CB846100
资助机构Xi&prime ; an Janssen Pharmaceutical Ltd ; Major State Basic Research Development Program of China (973 Program)
引用统计
被引频次:1[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/58044
专题北京大学精神卫生研究所
作者单位1.Shanghai Changzheng Hosp, Shanghai, Peoples R China
2.Peking Univ, Hosp 6, Inst Mental Hlth, Natl Clin Res Ctr Mental Disorders, Beijing 100871, Peoples R China
3.Jilin Univ, Hosp 1, Changchun 130023, Jilin Province, Peoples R China
4.Nanjing Med Univ, Nanjing Brain Hosp, Nanjing, Jiangsu, Peoples R China
5.Capital Med Univ, Beijing Childrens Hosp, Beijing, Peoples R China
6.Soochow Univ, Affiliated Childrens Hosp, Suzhou, Peoples R China
7.Nanjing Med Univ, Nanjing Childrens Hosp, Nanjing, Jiangsu, Peoples R China
8.Xian Janssen Pharmaceut Ltd, Janssen Res & Dev Dept, Beijing, Peoples R China
推荐引用方式
GB/T 7714
Su, Yi,Li, Haibo,Chen, Yixin,et al. Remission Rate and Functional Outcomes During a 6-Month Treatment With Osmotic-Release Oral-System Methylphenidate in Children With Attention-Deficit/Hyperactivity Disorder[J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY,2015,35(5):525-534.
APA Su, Yi.,Li, Haibo.,Chen, Yixin.,Fang, Fang.,Xu, Tong.,...&Wang, Yufeng.(2015).Remission Rate and Functional Outcomes During a 6-Month Treatment With Osmotic-Release Oral-System Methylphenidate in Children With Attention-Deficit/Hyperactivity Disorder.JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY,35(5),525-534.
MLA Su, Yi,et al."Remission Rate and Functional Outcomes During a 6-Month Treatment With Osmotic-Release Oral-System Methylphenidate in Children With Attention-Deficit/Hyperactivity Disorder".JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY 35.5(2015):525-534.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Su, Yi]的文章
[Li, Haibo]的文章
[Chen, Yixin]的文章
百度学术
百度学术中相似的文章
[Su, Yi]的文章
[Li, Haibo]的文章
[Chen, Yixin]的文章
必应学术
必应学术中相似的文章
[Su, Yi]的文章
[Li, Haibo]的文章
[Chen, Yixin]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。